The burgeoning popularity of semaglutide , initially for blood sugar control , is creating significant buzz within the UK , prompting a notable shift in hormone trends. Availability these treatments remains a complex landscape, with NHS provision currently limited and private clinics offering prescriptions at a premium . Worries are being raised re